Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist

MYGN:US

35.1300 USD 0.3400 0.98%

As of 20:10:00 ET on 03/06/2015.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 34.6000 Day's Range: 34.1300 - 35.2100 Volume: 444,661
Previous Close: 34.7900 52wk Range: 31.5600 - 42.5000 1-Yr Rtn: -6.07%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 35.1600
  • 1D
  • 1M
  • 1Y
34.7900
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 23.0527
Estimated P/E(06/2015) 23.2341
Relative P/E vs. SPX 1.2417
Earnings Per Share (USD) (ttm) 1.5239
Est. EPS (USD) (06/2015) 1.5120
Est. PEG Ratio 1.6270
Market Cap (M USD) 2,563.97
Shares Outstanding (M) 72.99
30 Day Average Volume 963,082
Price/Book (mrq) 3.6190
Price/Sale (ttm) 3.5556
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderRobert Gardner HarrisonChief Information Officer
Jerry S LanchburyChief Scientific OfficerR Bryan RiggsbeeExec VP/CFO/Treasurer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil